Literature DB >> 20123643

Dapsone efficacy and adverse events in the management of mucous membrane pemphigoid.

Anne M Hegarty, Martyn Ormond, Maureen Sweeney, Tim Hodgson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20123643     DOI： 10.1684/ejd.2010.0847

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN： 1167-1122            Impact factor:   3.328


× No keyword cloud information.
  3 in total

Review 1.  Dapsone in dermatology and beyond.

Authors:  Gottfried Wozel; Christian Blasum
Journal:  Arch Dermatol Res       Date:  2013-12-06       Impact factor: 3.017

2.  Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.

Authors:  Gérôme Bohelay; Marina Alexandre; Christelle Le Roux-Villet; Ishaï Sitbon; Serge Doan; Isaac Soued; Jason Shourick; Laurie Rousset; Benoît Mellottee; Michel Heller; Nicole Lièvre; Coralie Zumelzu; Florence Morin; Sabine Grootenboer-Mignot; Eric Gabison; Frédéric Caux; Catherine Prost-Squarcioni; Philippe Musette
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

3.  European Guidelines (S3) on diagnosis and management of mucous membrane pemphigoid, initiated by the European Academy of Dermatology and Venereology - Part II.

Authors:  E Schmidt; H Rashid; A V Marzano; A Lamberts; G Di Zenzo; G F H Diercks; S Alberti-Violetti; R J Barry; L Borradori; M Caproni; B Carey; M Carrozzo; G Cianchini; A Corrà; F G Dikkers; C Feliciani; G Geerling; G Genovese; M Hertl; P Joly; J M Meijer; V Mercadante; D F Murrell; M Ormond; H H Pas; A Patsatsi; S Rauz; B D van Rhijn; M Roth; J Setterfield; D Zillikens; G Zambruno; B Horváth; F Caux
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-07-26       Impact factor: 6.166
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.